Severe asthma: oral corticosteroid alternatives and the need for optimal referral pathways.
Didier CataldoRenaud LouisAlain MichilsRudi PechéCharles PiletteFlorence SchleichVincent NinaneShane HanonPublished in: The Journal of asthma : official journal of the Association for the Care of Asthma (2020)
Targeted biologic therapies have revolutionized the treatment of uncontrolled severe asthma by reducing or even eliminating the need for OCS and improving other major outcomes. Novel agents are now rapidly increasing the therapeutic armamentarium, but additional efforts are needed to optimize referral pathways in order to ensure sustainable access to these therapies.